We are excited to announce that Zsuzsa Baranyai has recently begun a new research project funded by the “la Caixa” Postdoctoral Junior Leader Fellowship (Retaining), awarded to her in 2025.
Starting in December 2025, this project focuses on developing an advanced multimodal nanoplatform for the treatment of glioblastoma. It is designed to overcome the multiple biological barriers that drug delivery systems face following intravenous administration, including circulation, targeting, and penetration of the blood–brain barrier.